Developer docs
API playgroundTry for free, no card

Search company profiles

Bionical

Full company profile

uuid0009xgx

Namestring
Bionical
Legal namestring
Bionical Solutions
Websiteurl
bionical.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

Bionical Solutions is a privately held UK-headquartered digital health engagement specialist founded in 2009, delivering bespoke digital solutions to pharmaceutical organisations and the UK NHS / public health sector. The company personalises content and digital experiences for healthcare professionals (HCPs) and patients, addressing pain points such as shrinking sales teams with rising cost-per-call, weak multi-channel data quality, the need for regionalised/personalised HCP content, and patient adherence and compliance. Core offerings are organised around three product lines: Healthware (a digital platform for personalising customer and patient experiences), Engagement Platforms (behaviour-change solutions that turn HCP and patient intent into action), and Bespoke Programs (custom digital programmes built to client specifications).

Under the hood, Bionical operates an in-house technology team that combines engineering capability with pharmaceutical and NHS domain expertise, supported by user research and CX/UX-led design. Its proprietary features include content customisation, personalisation and regionalisation, engagement platforms focused on behaviour change, and a data-and-insight layer that converts engagement telemetry into trusted, actionable insight for marketing and sales optimisation. Partnerships with Veeva and IQVIA provide integration into leading pharma CRM and healthcare analytics ecosystems, and certifications including ISO 9001, ISO 27001, Cyber Essentials, and Crown Commercial Service (CCS) supplier status underpin access to regulated pharma and public-sector procurement.

Bionical monetises through a sales-led, direct enterprise engagement model, delivering quote-based bespoke solutions under multi-year contracts. Revenue is concentrated in two primary segments — pharmaceutical organisations (HCP engagement, sales optimisation, content personalisation, adherence support) and NHS / public health organisations (patient journey management, outcome tracking). The company operates a UK global headquarters in Willington, Derbyshire, and a US regional headquarters in Flemington, New Jersey, serving international pharma clients from these bases. It is privately held with no disclosed funding rounds or institutional investors in the available materials.

Short descriptiontext

Bionical Solutions is a UK-headquartered digital health engagement specialist that designs, develops, and delivers bespoke digital platforms for pharmaceutical organisations and the NHS, personalising HCP and patient experiences to drive prescribing decisions, adherence, and measurable outcomes.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersWillington, United Kingdom
HQ citystring
Willington
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical digital solutions, healthcare engagement platforms, patient support programs, HCP engagement solutions, NHS digital services
Industry1 code
1Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
CodeHLALAFAFPrimaryYes
NAICS code1 code
  • Computer Systems Design Services541512
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
Product category
Healthcare Digital Engagement Solutions
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Bespoke Digital Solutions Development
TypeProfessional Services
Description

Custom digital solution development and delivery for pharmaceutical and healthcare organisations. The company designs and develops innovative digital solutions tailored to client specifications, working as a specialist partner to deliver engagement programs.

bionical.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Bespoke enterprise solutions - quote-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

No public pricing tiers available. Solutions are customised and tailored to client requirements, suggesting project-based or annual contract pricing.

bionical.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Bionical Solutions designs, develops and delivers bespoke digital solutions that personalise healthcare professional (HCP) and patient experiences for pharmaceutical organisations and NHS/public health bodies. The portfolio spans three offerings: Healthware (digital engagement infrastructure), Engagement Platforms (solutions driving HCP and patient behaviour change), and Bespoke Programs (custom-built digital programmes). Solutions focus on HCP engagement, patient adherence, prescribing decision support, content personalisation, and data-driven insight generation, delivered through multi-year enterprise contracts.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Bionical Solutions offers a unified digital solutions platform centred on personalising healthcare professional and patient experiences. The portfolio consists of three core product lines: Healthware (digital engagement infrastructure), Engagement Platforms (solutions for driving HCP and patient behaviour change), and Bespoke Programs (custom-built digital programmes for pharmaceutical and NHS clients). These products work together to deliver personalised content, improve patient adherence, and provide actionable data insights.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

Technology partnership displaying Veeva logo on website, indicating integration or technology interoperability with Veeva's pharmaceutical software suite

Strategic tierCoreTypeTechnology or Integration
Description

Technology partnership displaying IQVIA logo on website, indicating integration or technology interoperability with IQVIA's healthcare data and analytics platforms

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Salesforce Health Cloud provides a broad CRM and patient engagement layer used by life sciences and provider organizations, representing scaled incumbent competition to Bionical's vertical engagement platforms.

TypeEmerging player
Description

Sermo operates an HCP community and insights platform used by pharma for HCP engagement and market research, comparable in target audience and engagement mission to Bionical's platform-led offerings.

TypeEmerging player
Description

Within3 runs digital insights-engagement platforms (e.g., advisory boards, medical communications) for life sciences, comparable to Bionical's behavior-change and expert-engagement offerings.

TypeDirect peer
Description

IQVIA offers healthcare data, analytics, and commercial engagement tools serving the same pharma customer base as Bionical. Its dedicated patient and HCP engagement offerings directly overlap with Bionical's bespoke engagement programs.

TypeDirect peer
Description

OptimizeRx operates a point-of-care engagement and HCP marketing platform for pharma, closely aligned with Bionical's core use case of digital content delivery to HCPs and patients within treatment workflows.

TypeDirect peer
Description

PatientPoint delivers patient engagement programs in clinical settings and via digital channels, comparable to Bionical's patient engagement, adherence, and support solutions for pharma and providers.

TypeEmerging player
Description

Doceree powers programmatic HCP marketing and engagement via a physician-exclusive platform, targeting the same pharma marketing-budget pool that Bionical addresses through its Engagement Platforms.

TypeDirect peer
Description

Aktana provides AI-driven HCP engagement and next-best-action orchestration for pharma sales and marketing teams — a closely comparable solution set to Bionical's engagement platforms targeting the same buyer personas.

TypeDirect peer
Description

Real Chemistry is a healthcare marketing and communications firm building AI-enabled engagement programs for pharma and providers, directly competitive with Bionical's bespoke digital programs offering.

TypeDirect peer
Description

Veeva provides commercial and medical CRM for life sciences, overlapping directly with Bionical's HCP engagement and pharmaceutical sector focus. Bionical lists Veeva as a partner, making it both an adjacent peer and ecosystem gatekeeper.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bionical

Healthcare Digital Engagement Solutionsbionical.com

Bionical Solutions is a UK-headquartered digital health engagement specialist that designs, develops, and delivers bespoke digital platforms for pharmaceutical organisations and the NHS, personalising HCP and patient experiences to drive prescribing decisions, adherence, and measurable outcomes.

What Bionical does

Bionical Solutions is a privately held UK-headquartered digital health engagement specialist founded in 2009, delivering bespoke digital solutions to pharmaceutical organisations and the UK NHS / public health sector. The company personalises content and digital experiences for healthcare professionals (HCPs) and patients, addressing pain points such as shrinking sales teams with rising cost-per-call, weak multi-channel data quality, the need for regionalised/personalised HCP content, and patient adherence and compliance. Core offerings are organised around three product lines: Healthware (a digital platform for personalising customer and patient experiences), Engagement Platforms (behaviour-change solutions that turn HCP and patient intent into action), and Bespoke Programs (custom digital programmes built to client specifications).

Under the hood, Bionical operates an in-house technology team that combines engineering capability with pharmaceutical and NHS domain expertise, supported by user research and CX/UX-led design. Its proprietary features include content customisation, personalisation and regionalisation, engagement platforms focused on behaviour change, and a data-and-insight layer that converts engagement telemetry into trusted, actionable insight for marketing and sales optimisation. Partnerships with Veeva and IQVIA provide integration into leading pharma CRM and healthcare analytics ecosystems, and certifications including ISO 9001, ISO 27001, Cyber Essentials, and Crown Commercial Service (CCS) supplier status underpin access to regulated pharma and public-sector procurement.

Bionical monetises through a sales-led, direct enterprise engagement model, delivering quote-based bespoke solutions under multi-year contracts. Revenue is concentrated in two primary segments — pharmaceutical organisations (HCP engagement, sales optimisation, content personalisation, adherence support) and NHS / public health organisations (patient journey management, outcome tracking). The company operates a UK global headquarters in Willington, Derbyshire, and a US regional headquarters in Flemington, New Jersey, serving international pharma clients from these bases. It is privately held with no disclosed funding rounds or institutional investors in the available materials.

Bionical firmographics

Firmographics
Name
Bionical
Legal name
Bionical Solutions
Website
https://bionical.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
101–250 employees
Short description
Bionical Solutions is a UK-headquartered digital health engagement specialist that designs, develops, and delivers bespoke digital platforms for pharmaceutical organisations and the NHS, personalising HCP and patient experiences to drive prescribing decisions, adherence, and measurable outcomes.
Ownership category
akta.pro rank

Bionical industry classification

Industry
Product category
Healthcare Digital Engagement Solutions
NAICS
Computer Systems Design Services (541512)
SIC
Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
akta.pro primary industry
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)

Keywords

  • Pharmaceutical digital solutions
  • Healthcare engagement platforms
  • Patient support programs
  • HCP engagement solutions
  • NHS digital services

Where Bionical is headquartered

Location

Headquarters

HQ city
Willington
HQ country
United Kingdom
HQ region
Europe

Offices2 records

Markets served

Bionical business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Bespoke Digital Solutions Development: Custom digital solution development and delivery for pharmaceutical and healthcare organisations. The company designs and develops innovative digital solutions tailored to client specifications, working as a specialist partner to deliver engagement programs.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractBespoke enterprise solutions - quote-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Bionical product offering

Product offering

Core offering

Bionical Solutions designs, develops and delivers bespoke digital solutions that personalise healthcare professional (HCP) and patient experiences for pharmaceutical organisations and NHS/public health bodies. The portfolio spans three offerings: Healthware (digital engagement infrastructure), Engagement Platforms (solutions driving HCP and patient behaviour change), and Bespoke Programs (custom-built digital programmes). Solutions focus on HCP engagement, patient adherence, prescribing decision support, content personalisation, and data-driven insight generation, delivered through multi-year enterprise contracts.

Product overview

Bionical Solutions offers a unified digital solutions platform centred on personalising healthcare professional and patient experiences. The portfolio consists of three core product lines: Healthware (digital engagement infrastructure), Engagement Platforms (solutions for driving HCP and patient behaviour change), and Bespoke Programs (custom-built digital programmes for pharmaceutical and NHS clients). These products work together to deliver personalised content, improve patient adherence, and provide actionable data insights.

Differentiator

Problem solved

Functional benefit

Companies that use Bionical

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Bionical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Bionical partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • VeevacoreTechnology or IntegrationTechnology partnership displaying Veeva logo on website, indicating integration or technology interoperability with Veeva's pharmaceutical software suite
  • IQVIAcoreTechnology or IntegrationTechnology partnership displaying IQVIA logo on website, indicating integration or technology interoperability with IQVIA's healthcare data and analytics platforms

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Bionical competitors and assessment

Company assessment

Broad incumbents

  • Salesforce Health Cloud: Salesforce Health Cloud provides a broad CRM and patient engagement layer used by life sciences and provider organizations, representing scaled incumbent competition to Bionical's vertical engagement platforms.

Emerging players

  • Sermo: Sermo operates an HCP community and insights platform used by pharma for HCP engagement and market research, comparable in target audience and engagement mission to Bionical's platform-led offerings.
  • Within3: Within3 runs digital insights-engagement platforms (e.g., advisory boards, medical communications) for life sciences, comparable to Bionical's behavior-change and expert-engagement offerings.
  • Doceree: Doceree powers programmatic HCP marketing and engagement via a physician-exclusive platform, targeting the same pharma marketing-budget pool that Bionical addresses through its Engagement Platforms.

Direct peers

  • IQVIA: IQVIA offers healthcare data, analytics, and commercial engagement tools serving the same pharma customer base as Bionical. Its dedicated patient and HCP engagement offerings directly overlap with Bionical's bespoke engagement programs.
  • OptimizeRx: OptimizeRx operates a point-of-care engagement and HCP marketing platform for pharma, closely aligned with Bionical's core use case of digital content delivery to HCPs and patients within treatment workflows.
  • PatientPoint: PatientPoint delivers patient engagement programs in clinical settings and via digital channels, comparable to Bionical's patient engagement, adherence, and support solutions for pharma and providers.
  • Aktana: Aktana provides AI-driven HCP engagement and next-best-action orchestration for pharma sales and marketing teams — a closely comparable solution set to Bionical's engagement platforms targeting the same buyer personas.
  • Real Chemistry: Real Chemistry is a healthcare marketing and communications firm building AI-enabled engagement programs for pharma and providers, directly competitive with Bionical's bespoke digital programs offering.
  • Veeva Systems: Veeva provides commercial and medical CRM for life sciences, overlapping directly with Bionical's HCP engagement and pharmaceutical sector focus. Bionical lists Veeva as a partner, making it both an adjacent peer and ecosystem gatekeeper.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Bionical social profiles

Digital presence

Bionical compliance and trust

Trust signal

Compliance3 records

Bionical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bionical leadership team

Management profile

Number of profiles

Profiles1 record

Bionical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bionical M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bionical

What does Bionical do?

Bionical Solutions designs, develops and delivers bespoke digital solutions that personalise healthcare professional (HCP) and patient experiences for pharmaceutical organisations and NHS/public health bodies. The portfolio spans three offerings: Healthware (digital engagement infrastructure), Engagement Platforms (solutions driving HCP and patient behaviour change), and Bespoke Programs (custom-built digital programmes). Solutions focus on HCP engagement, patient adherence, prescribing decision support, content personalisation, and data-driven insight generation, delivered through multi-year enterprise contracts.

Is Bionical a public or private company?

Bionical is a private company. It is classified as unknown and is currently operating.

When was Bionical founded?

Bionical was founded in 2009. It employs 101 to 250 people.

Where is Bionical based?

Bionical is headquartered in Willington, United Kingdom, in the Europe region.

How does Bionical make money?

One revenue line is on record: bespoke Digital Solutions Development.

Who are Bionical's main competitors?

Salesforce Health Cloud is listed as a broad incumbent. Emerging players are Sermo, Within3 and Doceree. Direct peers are IQVIA, OptimizeRx, PatientPoint, Aktana, Real Chemistry and Veeva Systems.

Does Bionical have an API?

No public API is recorded for Bionical.

What industry is Bionical in?

Bionical's product category is Healthcare Digital Engagement Solutions. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs). Its NAICS code is 541512 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBionical Solutions Appoints Chief Technology Officer to Create Innovative Data Products and Software for the Digital BusinessBionical Solutions, a UK-based provider of technology-enabled healthcare services to pharmaceutical and biotech companies, appointed Andrew Seward as Chief Technology Officer for its Digital business. Seward brings over 12 years of experience, most recently serving as Head of Data Product Development at Experian Consumer Services, and has previously held CTO and product leadership roles at HR software, fintech, and tech startup companies. The appointment is intended to accelerate development of AI-powered data products and customized engagement platforms for the company's pharmaceutical industry clients.PR NewswireBionical Emas launches Expanded Access Program for JZP458 - a recombinant Erwinia AsparaginaseBionical Emas, a global specialist Clinical Research Organization, has launched a U.S. Expanded Access Program for Jazz Pharmaceuticals' investigational therapy JZP458, a recombinant Erwinia asparaginase for treating adult and pediatric patients with Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma. The therapy is designed for patients who have developed hypersensitivity or silent inactivation to E. coli-derived asparaginases, and JZP458 is currently under FDA review for marketing authorization in the United States. The program provides a mechanism for physicians to request access for eligible patients who have limited treatment options.PR NewswirePharmaMar and Bionical Emas Launch Expanded Access Program for Lurbinectedin in Relapsed Small Cell Lung Cancer in the U.S.PharmaMar and Bionical Emas have launched an Expanded Access Program (EAP) in the United States to provide lurbinectedin to patients with relapsed Small Cell Lung Cancer (SCLC) who have no other treatment options. SCLC is an aggressive cancer with limited effective treatments—the disease has not seen significant therapeutic advances in over two decades—and approximately 30,000 new cases are diagnosed annually in the U.S. PharmaMar filed for FDA accelerated approval of lurbinectedin in December 2019.PR NewswireBionical Group Ltd. Today Announces the Launch of Bionical-Clinical Early Access Programs (EAP)Bionical Group Ltd. announced the launch of Bionical Clinical Early Access Programs (EAP), which the company describes as the first and only global specialist EAP partner combining full CRO services with EAP expertise. The new service unit will provide pharma and biotech companies with comprehensive EAP support including regulatory strategy, pharmacovigilance, patient support, and real-world evidence generation. The company stated the launch reflects growing global demand from patients and governments for earlier access to critical treatments.PR NewswireBionical Acquires Global Clinical Research Organisation Emas PharmaBionical announced the strategic acquisition of Emas Pharma, a global clinical research organization, to expand its integrated outsourced services for the pharmaceutical and biotechnology industries. The deal adds clinical research, pharmacovigilance, and regulatory capabilities to Bionical's existing portfolio, though specific financial terms were not disclosed. This marks Bionical's third acquisition in just over a year, following previous deals with North 51 and McCallan Healthcare.